Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Jagsonpal Pharma announced a buyback offer of up to 1.6 million equity shares, representing 2.39% of its total equity, for Rs. 250 per share. The total buyback size is Rs. 40 crore, offering a premium of approximately 40% over recent market prices. The record date for determining eligible shareholders is May 4, 2026, and promoters will not participate.
Apr 29 2026 17:04:00
Jagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board approves Dividend
Jagsonpal Pharmaceuticals board recommended a ₹4 per equity share dividend for FY26. This 200% payout is subject to shareholder approval at the upcoming AGM.
Apr 27 2026 21:04:00
Jagsonpal Pharmaceuticals Ltd - 507789 - Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 16,00,000 Fully Paid-Up Equity Shares Of
Face Value ?2/- Each At A Price Of ?250/- Per Share, For An Aggregate Amount Not Exceeding ?40 Crores
Jagsonpal Pharmaceuticals announced May 04, 2026 as the record date for its buyback. The company plans to acquire up to 16 lakh equity shares at ₹250/share, totaling ₹40 crores.
Apr 27 2026 20:04:00
Jagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board to consider Dividend
Jagsonpal Pharmaceuticals board recommended a ₹4 per equity share dividend for FY26. This 200% payout is subject to shareholder approval at the upcoming AGM.
Apr 27 2026 19:04:00
Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting
Jagsonpal Pharmaceuticals reported FY26 revenue of ₹287.23 crore, up 6.88% YoY, and a net profit of ₹43.08 crore, down 22.2% YoY. The board also recommended a final dividend of ₹4 per equity share for the year ended March 31, 2026.
Apr 27 2026 19:04:00
Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Jagsonpal Pharmaceuticals shareholders approved buyback of up to 16 lakh equity shares at ₹250 each, totalling ₹40 crores, through postal ballot. The resolution passed with 99.99% votes in favour.
Apr 27 2026 07:04:00
Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Jagsonpal Pharmaceuticals shareholders approved buyback of up to 16 lakh equity shares at ₹250 each, totalling ₹40 crores, through postal ballot. The resolution passed with 99.99% votes in favour.
Apr 27 2026 07:04:00
Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Prior Intimation Of Board Meeting
Jagsonpal Pharmaceuticals board meeting is scheduled for April 27, 2026. The agenda includes considering and approving the Q4 FY26 audited financial results and a dividend recommendation for the financial year ending March 31, 2026.
Apr 20 2026 17:04:00
Read More